Aeolus Pharmaceuticals Company

Aeolus Pharmaceuticals develops lead compound, AEOL-10150, as a treatment for the pulmonary and delayed effects of acute radiation exposure.
Technology: undisclosed
Industry: Small&Large Molecules
Headquarters: California, United States
Founded Date: 1994
Employees Number: 1-10
Funding Status: IPO

Visit Website
info@aolsrx.com
https://www.twitter.com/aeoluspharma
Register and Claim Ownership